Vitamin D status among preterm infants with cholestasis and metabolic bone disease

Supamit Ukarapong1, Walter Zegarra2, Cristina Navarrete3

  • 1Pediatric Endocrinology, University of Miami, Miami, FL, USA. s.ukarapong@med.miami.edu.

Pediatric Research
|July 23, 2019
PubMed

Insights

Preterm infants with metabolic bone disease (MBD) and cholestasis generally maintain normal vitamin D levels. While vitamin D levels may decrease initially in cholestasis patients, deficiency rates remain similar across groups.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Metabolic bone disease (MBD) is a frequent complication in preterm infants.
  • Cholestasis has been identified as a significant risk factor for MBD development.
  • This study investigates vitamin D status in preterm infants experiencing both MBD and cholestasis.

Purpose of the Study:

  • To assess vitamin D status in preterm infants diagnosed with MBD.
  • To compare vitamin D levels between preterm infants with MBD and cholestasis versus those with MBD alone.
  • To determine the prevalence of vitamin D deficiency in these infant populations.

Main Methods:

  • Retrospective review of medical records for preterm infants in a NICU from June 2014 to May 2016.
  • Collection and analysis of demographic data, biochemical markers, and vitamin D intake.
  • Comparison of serum 25-hydroxyvitamin D levels at diagnosis and follow-up between cholestasis and non-cholestasis groups.

Main Results:

  • Serum 25-hydroxyvitamin D levels were similar at MBD diagnosis in infants with and without cholestasis (median 29.1 ng/ml vs. 28.7 ng/ml).
  • At follow-up (approx. 6 weeks later), vitamin D levels were significantly lower in the cholestasis group (median 31.2 ng/ml vs. 36.5 ng/ml, p=0.02).
  • Despite the decrease, the percentage of infants with vitamin D deficiency was comparable between the cholestasis and non-cholestasis groups.

Conclusions:

  • The majority of preterm infants with cholestasis and MBD exhibit adequate vitamin D status.
  • While a transient decrease in vitamin D levels may occur in cholestasis, it does not necessarily lead to deficiency.
  • These findings suggest that routine vitamin D monitoring may be warranted, with careful consideration of cholestasis in preterm infants with MBD.
Abstract

Related Concept Videos

Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.1K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
What is Metabolism?00:52

What is Metabolism?

Overview
131.2K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
218
Marcia's Theory of Identity Status01:26

Marcia's Theory of Identity Status

James Marcia's identity status model provides a framework for understanding how adolescents navigate identity formation through varying degrees of exploration and commitment. Marcia's model builds on Erik Erikson's theories of psychosocial development, focusing specifically on how adolescents reconcile individual aspirations with societal expectations. His model describes identity formation as a dynamic process where adolescents move between different states depending on their level...
1.5K
Mineral, Vitamin and Water Absorption01:27

Mineral, Vitamin and Water Absorption

Electrolytes are essential minerals and ions primarily obtained from the diet and absorbed through the gastrointestinal tract. Most electrolytes are absorbed in the small intestine. While the absorption of iron and calcium primarily occurs in the duodenum, calcium is also absorbed in the jejunum and ileum. In these regions, passive diffusion contributes to its absorption alongside active transport mechanisms in the duodenum. These ions can exit the enterocytes through specialized active...
1.5K